Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Letters: Observations

Cockcroft’s Formula Underestimates Glomerular Filtration Rate in Diabetic Subjects Treated by Lipid-Lowering Drugs

  1. Caroline Perlemoine, MD1,
  2. Vincent Rigalleau, MD, PHD1,
  3. Laurence Baillet, MD1,
  4. Nicole Barthe, MD2,
  5. Marie-Christine Delmas-Beauvieux, PD3,
  6. Catherine Lasseur, MD4 and
  7. Henri Gin, MD, PHD1
  1. 1Haut-Leveque Hospital, Nutrition-Diabetologie, Pessac, France
  2. 2Hospital Pellegrin, Médecine Nucléaire, Bordeaux, France
  3. 3Haut-Leveque Hospital, Laboratoire de biochimie, Pessac, France
  4. 4Hospital Pellegrin, Néphrologie, Bordeaux, France
    Diabetes Care 2002 Nov; 25(11): 2106-2107. https://doi.org/10.2337/diacare.25.11.2106-a
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    Diabetic subjects are often dyslipemic and have to be treated by fibrates or statins. These drugs must be cautiously used (and sometimes withdrawn) when chronic renal failure is present. Accurate evaluation of glomerular filtration rate (GFR) is thus of crucial importance in diabetic patients to detect early renal impairment. The Cockroft-Gault formula estimates glomerular function as a function of age, body weight, and serum creatinine, and is recommended by the American Diabetes Association (1).

    We evaluated the accuracy of Cockroft’s formula (CF) for predicting GFR, by reference to 51Cr-EDTA clearance, in 48 diabetic subjects without important renal failure (GFR >60 ml/min).

    Diabetic subjects were divided into two groups: 22 were not treated by lipid-lowering drugs (TTT−) and 26 were treated (TTT+; 22 with statin, 4 with fibrates). Results of plasma creatinine, isotopic GFR, CF calculated clearance, and the percent underestimation of CF as compared with isotopic GFR were compared by nonparametric tests (Mann-Whitney U for unpaired and Wilcoxon signed rank for paired data). Number of underestimated (<60 ml/min) CF in both groups was compared by the χ2 test. Results are expressed as mean ± SD.

    The two groups had similar BMI, (TTT− 26.8 ± 3.5 kg/m2 vs. TTT+ 28.7 ± 5.3 kg/m2; NS) and HbA1c (TTT− 9.0 ± 1.7 vs. TTT−+: 9.3 ± 1.2%; NS). Patients who were not treated were younger than treated patients (50.9 ± 15.9 vs. 61.9 ± 11.6 years; P < 0.01). Total, HDL, and LDL cholesterol did not significantly differ in the two groups. Triglycerides remained higher in treated patients (TTT− 1.5 ± 1.3 g/l vs. TTT+ 2.2 ± 1.5 g/l; P < 0.01). The degree of albuminuria was similar in the two groups (TTT− 168.9 ± 187 mg/24 h vs. TTT+ 275.3 ± 552 mg/24 h; NS).

    Despite the fact that treated patients were older than the patients who were not treated, isotopic GFR was only slightly lower in this group of patients (TTT+ 98.5 ± 33.9 ml/mn vs. TTT− 102.3 ± 31.5 ml/mn; NS). Plasma creatinine was slightly higher in the treated group (TTT− 88 ± 15 μmol/l vs. TTT+ 95 ± 20 μmol/l; NS). CF underestimated GFR in both nontreated (TTT− 94.3 ± 27 ml/min, P < 0.01 vs. isotopic GFR) and treated subjects (TTT+ 82.3 ± 30.7 ml/min, P < 0.0005 vs. isotopic GFR). However, the percent underestimation by CF was greater in treated (TTT− −6.4 ± 1.7%, TTT+ −15.1 ± 2%; P < 0.05). In the entire population the percent underestimation of GFR by CF was not correlated with age. Number of falsely renal insufficient subjects according to CF (CF <60 ml/min) was higher in treated subjects (TTT− 3 of 22 = 13.6%, TTT+ 8 of 26 = 30.7%; P < 0,05).

    CF is known to underestimate GFR at high values (2), but we find this was more pronounced in diabetic subjects treated with lipid-lowering drugs, despite the fact that their isotopic GFR was slightly lower. This underestimation was not associated with age. Indeed, the agreement between the true GFR and the estimated creatinine clearance depends on the former and should be closest when GFR is <100 ml/min (3), as found in the treated group. It does not depend on the age that is already included in CF. This underestimation may be due to the influence of these drugs on muscles (4) and muscular creatinine production, as already reported with fibrates (5). The use of CF may lead physicians to falsely consider one-third of treated diabetic subjects as renal insufficient and consequently erroneously reduce or withdraw lipid-lowering drugs, based on the proportion whose calculated GFR is falsely <60 ml/min. However, treatment of dyslipidemia is of crucial importance in patients with diabetic nephropathy. Indeed, lipid nephrotoxicity has been identified as a factor involved in the progression of renal injury (6).

    Footnotes

    • Address correspondence to Caroline Perlemoine, Nutrition-Diabetologia, Service du Pr GIN, Hopital Haut Levesque, 33 600 Pessac, France. E-mail: caroline.perlemoine{at}wanadoo.fr.

    • DIABETES CARE

    References

    1. ↵
      American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 24(Suppl. 1):S33–S43, 2001
      OpenUrlCrossRef
    2. ↵
      McElduff A, Shuter B, Cooper R, Davies L, Fulcher G, Hoschl R, Wilmshurst E: Measuring renal function in patients with diabetes mellitus. J Diabetes Complications 11:225–229, 1997
      OpenUrlPubMed
    3. ↵
      Sampson MJ, Drury PL: Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine. Diabetes Care 15:609–612, 1992
      OpenUrlAbstract/FREE Full Text
    4. ↵
      Hodel C: Myopathy and rhabdomyolysis with lipid-lowering drugs. Toxicol Lett 128:159–168, 2002
      OpenUrlCrossRefPubMedWeb of Science
    5. ↵
      Hottelart C, el Esper N, Achard JM, Pruna A, Fournier A: Fenofibrate increases blood creatinine, but does not change the glomerular filtration rate in patients with mild renal insufficiency (French). Néphrologie 20:41–44, 1999
      OpenUrlPubMedWeb of Science
    6. ↵
      Gin H, Rigalleau V, Aparicio M: Lipids, protein intake, and diabetic nephropathy. Diabet Metab 26:45–53, 2000
    PreviousNext
    Back to top
    Diabetes Care: 25 (11)

    In this Issue

    November 2002, 25(11)
    • Table of Contents
    • About the Cover
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes Care.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Cockcroft’s Formula Underestimates Glomerular Filtration Rate in Diabetic Subjects Treated by Lipid-Lowering Drugs
    (Your Name) has forwarded a page to you from Diabetes Care
    (Your Name) thought you would like to see this page from the Diabetes Care web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Cockcroft’s Formula Underestimates Glomerular Filtration Rate in Diabetic Subjects Treated by Lipid-Lowering Drugs
    Caroline Perlemoine, Vincent Rigalleau, Laurence Baillet, Nicole Barthe, Marie-Christine Delmas-Beauvieux, Catherine Lasseur, Henri Gin
    Diabetes Care Nov 2002, 25 (11) 2106-2107; DOI: 10.2337/diacare.25.11.2106-a

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Cockcroft’s Formula Underestimates Glomerular Filtration Rate in Diabetic Subjects Treated by Lipid-Lowering Drugs
    Caroline Perlemoine, Vincent Rigalleau, Laurence Baillet, Nicole Barthe, Marie-Christine Delmas-Beauvieux, Catherine Lasseur, Henri Gin
    Diabetes Care Nov 2002, 25 (11) 2106-2107; DOI: 10.2337/diacare.25.11.2106-a
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Weight Gain and Gestational Diabetes Mellitus Is a Sensitive Issue
    • Beneficial Effects of a 4-Week Exercise Program on Plasma Concentrations of Adhesion Molecules
    • Malignant Melanoma Misdiagnosed as a Diabetic Foot Ulcer
    Show more Letters: Observations

    Similar Articles

    Navigate

    • Current Issue
    • Standards of Care Guidelines
    • Online Ahead of Print
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.